Skip to main content
Signal8

Sussman Joel F.

SEC insider (Form 3/4/5 filer). CIK 0001774297. Chief Accounting Officer at Galera Therapeutics, Inc. (GRTX). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in MALVERN, PA.

Companies Sussman Joel F. has filed insider reports for

  • Galera Therapeutics, Inc. (GRTX): Officer, Chief Accounting Officer
Sussman Joel F. profile photo

Sussman Joel F.

CIK: 0001774297

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Galera Therapeutics, Inc. logo
GRTX

Galera Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Galera Therapeutics, Inc. logo
    GRTX

    Galera Therapeutics, Inc.

    Aug 3, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    10K shares-
  • Galera Therapeutics, Inc. logo
    GRTX

    Galera Therapeutics, Inc.

    May 1, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    2M shares-

1-2 of 2